Basics Elanco Animal Health Incorporated IPO Date: September 17, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $6.55B Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 1.63% Avg Daily Range (30 D): $0.21 | 1.90% Avg Daily Range (90 D): $0.21 | 2.05% Institutional Daily Volume Avg Daily Volume: 4.33M Avg Daily Volume (30 D): 5.55M Avg Daily Volume (90 D): 4.75M Trade Size Avg Trade Size (Sh.): 152 Avg Trade Size (Sh.) (30 D): 142 Avg Trade Size (Sh.) (90 D): 140 Institutional Trades Total Inst.Trades: 14,030 Avg Inst. Trade: $3.42M Avg Inst. Trade (30 D): $2.81M Avg Inst. Trade (90 D): $2.61M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 8 Market Closing Trades Avg Closing Trade: $12.08M Avg Closing Trade (30 D): $8.45M Avg Closing Trade (90 D): $7.39M Avg Closing Volume: 579.9K         News May 7, 2025 @ 3:03 PM Animal Health Elanco Chirps A Solid Quarter Temper... Source: Vandana Singh May 5, 2025 @ 8:40 PM Elanco Animal Health Sells Xdemvy Royalties To Bla... Source: Vandana Singh Mar 6, 2025 @ 1:25 AM Shareholder Alert: Johnson Fistel, LLP Investigate... Source: Johnson Fistel, Llp Feb 14, 2025 @ 3:57 PM Poultry Vaccine & Drug Market Booming as Demand fo... Source: Globe Newswire Jan 8, 2025 @ 3:55 PM Growth Trends in the Porcine Vaccines Market, Fore... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $.76 $.14 $-.02 Diluted EPS $.74 $.13 $-.02 Revenue $ 4.43B $ 1.19B $ 1.02B Gross Profit $ 2.43B $ 684M $ 519M Net Income / Loss $ 373M $ 67M $ -8M Operating Income / Loss $ 536M $ 60M $ -51M Cost of Revenue $ 2B $ 509M $ 501M Net Cash Flow $ 142M $ 19M $ -22M PE Ratio 18.16